Inventor · disambiguated record
Jinquan Luo
Also filed as: LUO JINQUAN
51 granted patents·28 pending applications·344 citations·filing 2004–2025
98Inventor score
Files withJANSSEN BIOTECH INC45CUNNINGHAM MARK7JANSSEN PHARMACEUTICA NV6BENSON JACQUELINE3BIOCEROX PROD BV3
Top patents by PatentIndex Score
79 records- 0198US7491391B2Anti-IL-23 antibodies, compositions, methods and usesCENTOCOR INC·Filed 2006·Granted Feb 17, 2009·115 cites·14 claims
- 0296US11236155B2Antibodies to pyroglutamate amyloid-β and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 1, 2022·4 cites·23 claims
- 0396US7807414B2Anti-IL-23 antibodies, compositions, methods and usesCENTOCOR ORTHO BIOTECH INC·Filed 2009·Granted Oct 5, 2010·36 cites·12 claims
- 0492US11746161B2Antibodies that specifically bind PD-1 and methods of useJANSSEN BIOTECH INC·Filed 2020·Granted Sep 5, 2023·3 cites·15 claims
- 0592US9850310B2CD123 binding agents and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Dec 26, 2017·23 cites·20 claims
- 0692US9090694B2ST2L antibody antagonistsJANSSEN BIOTECH INC·Filed 2013·Granted Jul 28, 2015·19 cites·4 claims
- 0791US12084501B2Proteins comprising CD3 antigen binding domains and uses thereofJANSSEN BIOTECH INC·Filed 2022·Granted Sep 10, 2024·2 cites·44 claims
- 0891US9522957B2Method of treating an inflammatory condition by administering toll-like 3 receptor antagonistsJANSSEN BIOTECH INC·Filed 2013·Granted Dec 20, 2016·10 cites·7 claims
- 0991US9428579B2Method of treating Crohn's disease by administering an anti-IL-12 antibodyJANSSEN BIOTECH INC·Filed 2014·Granted Aug 30, 2016·8 cites·8 claims
- 1091US8080247B2Anti-IL-12 antibodiesGILES-KOMAR JILL·Filed 2005·Granted Dec 20, 2011·10 cites·10 claims
- 1190US9481731B2Toll-like receptor 3 antagonistsJANSSEN BIOTECH INC·Filed 2013·Granted Nov 1, 2016·9 cites·10 claims
- 1290US9255153B2Polynucleotides encoding Toll-Like Receptor 3 antagonistsCUNNINGHAM MARK·Filed 2013·Granted Feb 9, 2016·10 cites·9 claims
- 1390US9212227B2ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditionsJANSSEN BIOTECH INC·Filed 2013·Granted Dec 15, 2015·13 cites·15 claims
- 1490US8519107B2IL-17A antibodiesALMAGRO JUAN CARLOS·Filed 2010·Granted Aug 27, 2013·24 cites·16 claims
- 1587US10781246B2Compositions and methods for anti-staphylococcal biologic agentsUNIV NEW YORK·Filed 2016·Granted Sep 22, 2020·5 cites·15 claims
- 1687US9862766B2Method of treating lupus by administering an anti-IL-12 antibodyJANSSEN BIOTECH INC·Filed 2017·Granted Jan 9, 2018·3 cites·10 claims
- 1786US10844122B2Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereofJANSSEN BIOTECH INC·Filed 2016·Granted Nov 24, 2020·4 cites·8 claims
- 1885US10759854B2Interferon alpha and omega antibody antagonistsJANSSEN BIOTECH INC·Filed 2019·Granted Sep 1, 2020·2 cites·13 claims
- 1985US9790281B2Humanized anti-CD134 (OX40) antibodies and uses thereofBIOCEROX PROD BV·Filed 2014·Granted Oct 17, 2017·10 cites·7 claims
- 2084US9951137B2ST2L antagonists and methods of useJANSSEN BIOTECH INC·Filed 2015·Granted Apr 24, 2018·4 cites·6 claims
- 2184US8329170B2Method for treating psoriasis by administering an anti-IL-12 antibodyGILES-KOMAR JILL·Filed 2011·Granted Dec 11, 2012·4 cites·8 claims
- 2283US10576150B2Anti-IL-23 antibodiesJANSSEN BIOTECH INC·Filed 2019·Granted Mar 3, 2020·1 cites·11 claims
- 2382US9238693B2Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodiesCUNNINGHAM MARK·Filed 2013·Granted Jan 19, 2016·3 cites·9 claims
- 2481US10995149B2Antibodies that specifically bind PD-1 and methods of useJANSSEN BIOTECH INC·Filed 2018·Granted May 4, 2021·2 cites·19 claims
- 2581US10272152B2Anti-IL-23 antibodies, compositions, methods and usesJANSSEN BIOTECH INC·Filed 2017·Granted Apr 30, 2019·1 cites·11 claims
- 2680US12161716B2Anti-IL-23 antibodies, compositions, methods and usesJANSSEN BIOTECH INC·Filed 2021·Granted Dec 10, 2024·0 cites·2 claims
- 2780US11787875B2Materials and methods for improved single chain variable fragmentsJANSSEN BIOTECH INC·Filed 2020·Granted Oct 17, 2023·1 cites·26 claims
- 2880US8409567B2Toll-like receptor 3 antagonistsCUNNINGHAM MARK·Filed 2009·Granted Apr 2, 2013·2 cites·17 claims
- 2980US2025320286A1Antibodies to pyroglutamate amyloid-b and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2025·Application pending·0 cites
- 3079US10273307B2Humanized anti-CD134 (OX40) antibodies and uses thereofBIOCEROX PROD BV·Filed 2017·Granted Apr 30, 2019·3 cites·17 claims
- 3178US10208113B2Interferon α and ω antibody antagonistsJANSSEN BIOTECH INC·Filed 2015·Granted Feb 19, 2019·2 cites·19 claims
- 3278US9932404B2Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonistJANSSEN BIOTECH INC·Filed 2016·Granted Apr 3, 2018·1 cites·18 claims
- 3378US8540986B2Toll-like receptor 3 antagonistsCUNNINGHAM MARK·Filed 2010·Granted Sep 24, 2013·2 cites·9 claims
- 3476US10633435B2Anti-PHF-tau antibodies and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Apr 28, 2020·1 cites·19 claims
- 3576US10450377B2ST2L antagonists and methods of useJANSSEN BIOTECH INC·Filed 2018·Granted Oct 22, 2019·1 cites·18 claims
- 3676US10358491B2Interferon alpha and omega antibody antagonistsJANSSEN BIOTECH INC·Filed 2018·Granted Jul 23, 2019·1 cites·8 claims
- 3776US8574579B2Anti-IL-23 antibodiesBENSON JACQUELINE·Filed 2012·Granted Nov 5, 2013·1 cites·13 claims
- 3875US11185584B2Anti-IL-23 antibodies, compositions, methods and usesJANSSEN BIOTECH INC·Filed 2020·Granted Nov 30, 2021·0 cites·2 claims
- 3975US2025145711A1Proteins comprising cd3 antigen binding domains and uses thereofJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 4073US8460659B2Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseasesCUNNINGHAM MARK·Filed 2011·Granted Jun 11, 2013·2 cites·5 claims
- 4173US2023340155A1Antibodies that Specifically Bind PD-1 and Methods of UseJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 4271US2022106387A1Antibodies to pyroglutamate amyloid-b and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 4370US2024124583A1Proteins Comprising Kallikrein Related Paptidase 2 Antigen Binding Domains And Their UsesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 4469US2019085069A1Anti-IL-12 Antibodies, Epitopes, Compositions, Methods and UsesJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 4569US2024067754A1Materials and methods for improved single chain variable fragmentsJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 4668US9127058B2Anti-IL-23 AntibodiesJANSSEN BIOTECH INC·Filed 2013·Granted Sep 8, 2015·0 cites·8 claims
- 4768US9096667B2Anti-IL-23 antibodies, compositions, methods and usesJANSSEN BIOTECH INC·Filed 2013·Granted Aug 4, 2015·0 cites·8 claims
- 4868US2025136688A1Stabilized cd3 antigen binding agents and methods of use thereofJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 4967US9714287B2Anti-IL-23 antibody compositionsJANSSEN BIOTECH INC·Filed 2016·Granted Jul 25, 2017·0 cites·11 claims
- 5067US9062305B2Generation of human de novo pIX phage display librariesTSUI PING·Filed 2009·Granted Jun 23, 2015·2 cites·1 claims
Showing the top 50 of 79 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →